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Implication for health policy/practice/research/medical education:
Methanol extracts from different parts of Prangos acaulis showed significant antibacterial activity against the single form of S. mutans 
and inhibited biofilm formation without any mutagenic activity. The extracts showed significance antibacterial and antibiofilm 
activities against the test microorganism in a dose dependent manner, which could be contributed to ar-curcumene, d-limonene and 
alpha-pinene. Hence, this plant can be considered as a candidate for preparation of a new drug against microorganisms.
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Prangos acaulis Bornm. extract against Streptococcus mutans: an in silico and in vitro study. J Herbmed Pharmacol. 2018;7(3):176-
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Introduction: Streptococcus mutans is a principal pathogenic agent in biofilm formation 
on the teeth surfaces and subsequently development of dental caries and plaque. Therefore, 
currently introducing novel anti-bacterial and anti-biofilm agents, especially plant based 
materials are highly regarded. This study was planned to investigate in silico and in vitro 
antibacterial activities of Prangos acaulis extracts against S. mutans in single and biofilm 
forms and their mutagenicity in Ames test. 
Methods: The anti-bacterial and anti-biofilm effects of methanol extracts from various parts 
of P. acaulis were evaluated using disk diffusion and microtiter assay. Moreover, the potential 
mutagenicity of the extracts was investigated using Ames test. In addition, dominant constitutes 
of P. acaulis that reported in previous studies were subjected to an in silico analysis. The ability 
of selected phytochemicals to inhibit the glucosyltransferase was evaluated using molecular 
docking method. 
Results: All tested extracts especially root extract had significant antibacterial activity against 
the single form of S. mutans and inhibited biofilm formation without any mutagenic activity. 
The results also confirmed that three compounds consisting of ar-curcumene, d-limonene and 
alpha-pinene had strong and appropriate interactions to glucosyltransferase. 
Conclusion: This study indicated that P. acaulis has potent antibacterial and biofilm inhibition 
activity against S. mutans and can be good candidate for in vitro and in vivo studies with the aim 
of introducing novel inhibitors of dental caries development.
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A B S T R A C T
Introduction
Dental caries is a multifactorial complication and one 
of the most common infectious diseases in the world 
(1). Streptococcus mutans is one of the key factors in 
development of dental plaque and caries due to the 
ability for formation of biofilms and colonization on 
the dental surface in the presence of sucrose. S. mutans 
has different virulence factors such as mutacins, lactate 
dehydrogenase (LDH), antigen B, fructosyltransferase 
(Ftf), non-enzymatic glucan-binding proteins (GBPs) 
and glucosyltransferases (GTFs) which have vital 
roles in colonization and accumulation on dental 
surfaces (2,3). Among the mentioned virulence factors, 
glucosyltransferase is the key factor in demineralization of 
the tooth surface, the biofilm formation and development 
of dental caries. The sticky polymer of sucrose named 
glucan produced by glucosyltransferase of S. mutans 
is an initiating factor for dental caries formation due 
to trapping oral bacteria, food debris and salivary 
components. The secreted acids by trapped bacteria in 
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the glucan polymer break down the enamel on the surface 
of teeth causing dental caries (4,5). Due to key role of 
the glucosyltransferase in formation and development 
of dental caries, many studies have been conducted to 
introduce novel glucosyltransferase inhibitors (6-9). 
Glucosyltransferase is an enzyme (GTF-SI) encoded by 
gtf gene, composed of eight chains including A, B, C, D, 
E, F, G and H. This enzyme plays a key role in biofilm 
formation and colonization of S. mutans on dental surface. 
The enzyme is a member of glycoside hydrolase family 70 
that catalyzes the formation of glucan with different types 
of glucosidic linkage such as α (1-3), α (1-4) and α (1-6) 
(10-12). Presently, there is a lot of interest in investigation 
of natural materials especially plant materials as a good 
source of new inhibitors for glucosyltransferase of S. 
mutans and prevention of dental caries. Medicinal plants 
have long been used for prevention and treatment of 
infectious diseases due to their availability, proper effects, 
low cost, variety and presence of a wide range of herbal 
compounds with therapeutic effects (13-19). The genus 
Prangos that is known Jashir in Iran belongs to Apiaceae 
family. The plants of this genus are widely used in folk 
medicine to treat external bleeding, scars of worms, 
digestive disorders, leukoplakia and infectious diseases as 
the antimicrobial agent (20). P. acaulis Bornm. is one of the 
important species of genus Prangos in Iran that is used in 
folk medicine as Sedative and anti-infective agent (21,22). 
This plant is used in traditional  medicine in some areas 
of Iran as pain relief and tooth whitener. Therefore, the 
plant was selected for investigation of the anti-bacterial 
and anti-biofilm activities against S. mutans.
Despite numerous drug properties, plants can include 
mutagenic compounds (23-25). Therefore, investigation 
of the mutagenic potential of plant materials is essential. 
Consequently, along with anti-bacterial properties of the 
plant extracts probable mutagenicity of them was also 
evaluated for the first time using Ames test. Designing 
or screening new drug compounds using conventional 
methods are costly and time consuming along with 
possibility of human mistakes. Therefore, in recent years 
in silico methods for drug discovery and development are 
highly regarded. Bioinformatics is playing an increasingly 
key role in drug target identification, drug candidate 
screening, and refinement as well as characterization of 
side effects and prediction of drug resistance (26,27). In 
the present study, the antibacterial and anti-biofilm as 
well as mutagenicity activity of methanolic extracts from 
different parts of P. acaulis were investigated. Furthermore, 
in silico analysis was used for screening new inhibitor(s) 
for glucosyltransferase of S. mutans.
Materials and Methods
In silico analysis
Retrieval of receptor and ligands from database
Fifteen dominant compounds from P. acaulis, reported in 
previous studies (28,29), were selected for in silico analysis 
(Table 1). The three-dimensional structures of all the 
phytochemicals and Benzyl penicillin as positive control 
were retrieved from PubChem database (http://pubchem.
ncbi.nlm.nih.gov). Moreover, a three-dimension structure 
of glucosyltransferase as a receptor was obtained from 
protein data bank (http://www.rcsb.org) with PDB entry 
3AIE.
Receptor and ligands preparation and optimization
The raw structure of glucosyltransferase and the ligands 
were further prepared for in silico analysis. For this aim, 
the receptor was initially made ready by removing all 
water molecules and none polar hydrogens, followed by 
subsequent energy minimization to remove the bad steric 
clashes using the UCSF Chimera-1.11.2 software. Also, all 
ligand molecules were minimized in term of energy and 
structure using ArgusLab 4.01 software.
Table 1. Major constitutes of Prangos acaulis (selected for molecular docking study)
Number Compound Pubchem CID Molecular Formula
1 Alpha-Thujene 12444324 C10H16
2 P-Cymene 7463 C10H14
3 Alpha-Pinene 6654 C10H16
4 Camphene 6616 C10H16
5 Beta-Pinene 14896 C10H16
6 Myrcene 31253 C10H16
7 Alpha-Terpinene 7462 C10H16
8 D-Limonene 440917 C10H16
9 Ar-Curcumene 92139 C15H22
10 Alpha-Humulene 5281520 C15H24
11 3-ethylidene-2-methyl-1-hexen-4-yne 4577834 (ChemSpider ID) C9H12
12 Germacrene D 5317570 C15H24
13 Terpineol 17100 C10H18O
14 Caryophyllene 5281515 C15H24
15 Nerol 643820 C10H18O
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Determination of binding site
The binding site(s) of glucosyltransferase were predicted 
using MOE software version 2010. The involved amino 
acids as well as the size of each binding site were also 
predicted.
Drug-likeness and toxicity prediction
Drug-likeness and safety of each compound must be 
evaluated to be a candidate as a drug. To calculate the 
molecular properties associated with drug-likeness 
(absorption, distribution, metabolism, and elimination) of 
the ligands SwissADME (http://www.swissadme.ch/index.
php) and MedChem Designer 3.0 were used. Moreover, 
genotoxicity potential of the ligands was predicted using 
Toxtree 2.6.6 software.
Molecular docking
The dominant phytochemicals from P. acaulis and 
glucosyltransferase were subjected to ligand-protein 
docking study. Molecular docking was performed 
using Autodock4 (version 1.5.6) with the Lamarckian 
genetic algorithm. Docking parameters which selected 
for AutoDock4 runs were as follows: 200 docking runs, 
population size of 200, random starting position and 
conformation, translation step ranges of 2A, mutation rate 
of 0.02, cross-over rate of 0.8, local search rate of 0.06 and 
2.5 million energy evaluations. Docked conformations 
were clustered by a tolerance of two Å root mean square 
deviations (RMSD). 
In vitro analysis
Plant materials
The fresh plant samples were collected from Kurdistan 
province of Iran from May to June 2016. The plants were 
authenticated by a botanist at the herbarium unit of the 
University of Isfahan, Iran. The plant parts were washed 
using tap water and then were separated into flower, leaf, 
stem, seed, and root. Afterward,  various parts were air 
dried in shadow for one week at room temperature, then 
powdered for extraction.
Preparation of plant extracts
The methanol extracts of different parts of P. acaulis were 
prepared using maceration method (30). Briefly, 100g of a 
powdered plant part was soaked in 300 mL of methanol for 
72 hours, then, filtered using Whatman filter paper. The 
collected extracts were concentrated by rotary vacuum 
evaporator (Stero glass, Italy) at 45°C and then dried 
using freeze dryer (Zirbus, Germany). All extracts were 
dissolved in dimethyl sulphoxide (DMSO) and diluted 
with to give concentrations of 250, 500, 1000, 1500, 2000 
and 3000 μg/mL.
Microorganisms and culture condition
The tested strains in the study for antibacterial and 
mutagenicity evaluation of the plant were S. mutans 
(PTCC 1683) and Salmonella typhimurium TA98 which 
were respectively purchased from Iranian Biological 
Resources Center (Tehran, Iran) and Bio Reliance 
Corporation (Rockville, MD, USA). S. mutans was 
grown on Nutrient Broth medium at 37˚C for 8 hours 
to subculture and prepare for antibacterial analysis. 
Furthermore, S. typhimurium TA98 was cultured on 
minimal glucose agar (1.5% agar, 2.0% glucose, and 2.0% 
Vogel-Bonner medium) containing histidine and biotin at 
37˚C for 18 hours to measure the mutagenic properties of 
plant materials.
Antibacterial activity 
Antibacterial activity of the P. acaulis extracts against 
the single form of S. mutans was investigated using disk 
diffusion method (31). For this, sterile Whatman filter 
papers No.1 were prepared and soaked separately in each 
of the extracts in different concentrations for 5 minutes, 
then placed on the plate for 24 hours at 37°C. In the 
next step, the zone of inhibition around the disc, which 
indicated antibacterial activity of tested extracts, was 
measured. In the study, standard discs of penicillin (10 
mg/disk) and DMSO were used as positive and negative 
controls, respectively.
Furthermore, the minimum inhibitory concentration 
(MIC) and minimum bactericidal concentration (MBC) 
values of tested extracts were determined by micro-
dilution method using 96-well microtiter plate (32). For 
these, 100 μL of each extract in tested concentration 
was added to all wells, which contained 100 μL of BHI 
(Brain Heart Infusion) medium and 20 μL of inoculums 
(containing about 6×104 colony) and incubated in 37°C 
for 24 hours. After incubation optical density of each 
well was read at 620 nm. In the study, a serial dilution of 
penicillin (25, 50, 100, 200, 400, 800, 1600 and 3200 μg/
mL) was considered as positive control. The MIC value 
was defined as the lowest concentration which inhibited 
the growth or fewer than three discrete colonies which 
were detected. Similarly, an MBC value was defined as 
the lowest concentration of the plant extracts to kill the 
microorganisms. Plates were read in triplicate, and the 
average of the MIC and MBC values were recorded.
Inhibition of biofilm formation
The effects of P. acaulis extracts on S. mutans were 
evaluated using microtiter plate assay (15). For this, the 
extracts were placed at different concentrations in the 
wells of a sterile polystyrene microtiter plates, previously 
treated with Saliva. After this, the microtiter plate wells 
containing 100 μl BHI medium with 2% sucrose were 
inoculated with 3 μL of the overnight grown culture 
of S. mutans (1.0 × 107 cells/mL in BHI medium), and 
the samples were incubated at 37°C for 18 hours. After 
incubation, 30 μL saline (0.85% NaCl) was added to each 
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well for removing loosely attached and nonadherent 
cells. In the next step, the wells were washed three times 
with sterile distilled water, and the  plates were dried for 
45 minutes before carrying out biofilm quantification. 
Biofilm growth and quantification were evaluated 
using the crystal violet staining method and measuring 
absorbance at 575 nm. The percentage of inhibition was 
calculated using the following formula:
Inhibition (%) = [(A575 of control-A575 sample)/ A575 of 
control] ×100
Mutagenicity assay
The mutagenic potential of the extracts was evaluated 
using Ames test based on mutagenicity in S. typhimurium 
TA98 with some modifications, as described previously 
(20). For this, 100 μL of an overnight grown culture (107 
CFU/mL) of the strain was added in sterile screw-capped 
tubes. Then, 2 mL of top agar (0.6% agar and 0.5% NaCl) 
and 100 μL of each extract were added to the tubes and 
vortexed. After this, the solution was poured onto a 
minimal glucose agar plate and was incubated at 37°C for 
48 hours. After incubation, numbers of His+ revertant 
colonies were counted. The positive and negative controls 
in this assay were sodium azide and sterile distilled water, 
respectively. The mutagenic effects of tested extracts were 
estimated using the twofold rule according to the following 
formula. The substance was considered mutagen if the 
QM value was calculated higher than two.
QM =Number of His+ revertant colonies from tested 
extracts/colonies from negative control
Statistical analysis 
The data were obtained in 30 replicates from three separate 
experiments and were expressed as mean ± standard 
deviation (SD) and then analyzed by SPSS V.21 using one-
way analysis of variance (ANOVA) and Duncan post hoc 
tests. Additionally, P values <0.05 were considered to be 
statistically significant  between different samples.
Results
Determination of binding site
The predicted binding sites of glucosyltransferase are 
presented in Table 2. The results showed that the enzyme 
has ten binding sites with different amino acid numbers. 
The size evaluation of predicted binding sits showed that 
the largest and smallest sits were 161 and 42 Å.
Drug-likeness and toxicity prediction
The results of calculation of drug-likeness and toxicity 
of the ligands are given in Table 3. The results confirmed 
that all studied compounds had suitable permeation and 
distribution with low toxicity. Furthermore, the results 
showed that the most studied compounds had low gastro-
intestine absorption except terpineol and nerol that GI 
absorption was predicted in a high level for them. The 
results also revealed that among studied compounds only 
camphene showed genotoxicity potential. 
Molecular docking
The results of molecular docking studies are shown in 
Table 4. Results revealed that three compounds including 
ar-curcumene, d-limonene and α-pinene had appropriate 
Table 2. The predicted binding sites of glucosyltransferase
Active site Size (Å) Residues
1 161
SER244 PHE245 ALA246 ASN249 GLN250 MET297 THR298 TRP299 TRP300 PRO301 ASP302 GLN303 GLN306 LEU330 
ASN333 LEU334 ALA336 GLN337 GLN340 ALA369 TRP370 GLN986 THR990 ALA1058 GLY1059 VAL1061 LEU1062 LYS1063 
ASP1064 GLN1065 TYR1O7O PHE1071 PRO1081 LYS1082 SER1083 LEU1084    
2 101
LEU382 TYR430 LEU433 LEU434 ARG475 ASP477 ALA478 ASP480 ASN481 GLU515 TRP517 ARG540 LEU541 LEU544 
HIS587 ASP588 SER589 GLU590 GLN592 ASP593 TYR610 ASN862 PHE907 ASP909 ASN914 TYR916 ALA917 VAL957 
GLN960 TYR962
3 140
ASP504 ALA573 GLU574 THR575 THR649 ASN650 LYS651 SER652 ARG687 ILE688 VAL691 SER692 GLY693 GLY694 ARG712 
GLY714 LYS715 GLY716 ALA717 LEU718 VAL830 ARG831 VAL832 ALA833 ALA834 SER835 GLN847 ASN848 ALA849 ALA850 
ASP852 SER853
4 79 ARG585 TYR624 ASN625 LEU628 LEU629 LYS633 THR636 HIS637 TYR638 ASN639 THR64O GLY660 ASP661 THR664 ASP665 LYS673 THR674 ILE675 ASN676 PRO810 GLN811
5 50 PHE663 GLN668 TYR669 MET67O ALA671 LYS673 TYR677 1YS869 GLU871 GLU872 VAL877 ASN881 LYS884 TRP888
6 62 ASP263 HIS264 TYR265 LY5394 LEU395 THR396 SER397 GLN398 THR1069 TYR1070 SER1072 LEU1073 VAL1074 ASN1077
7 53 LEU544 ALA548 LYS549 PRO550 GLU590 ASP593 LEU594 ASP597 LYS633 1Y5634 TYR635 THR636 HIS637 TYR638
8 42 SER372 GLU375 LEU382 GLN383 LY5384 VAL608 SER611 SER906 ASN1052 ILE1053 LEU1054 GLY1055
9 68 GLU681 THR682 LY5685 ALA686 LY5689 TYR690 ARG765 LEU767 TYR778 HI5779 SER780 ASP781 PRO821 GLY823 ALA824 ALA825 ALA826
10 59 LYS505 ASN508 ASP509 ARG831 VAL832 ALA833 ALA834 ALA850 LEU851 SER853 ARG854 ALA886 GLY889 VAL890 THR891 LYS948 GLY949 11E950 LYS951
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and robust interactions with glucosyltransferase  in 
comparison to penicillin and other tested phytochemicals. 
The results also confirmed that most of the interactions are 
van der Waals forces and c-terminal amino acid residues 
of the enzyme have key roles in enzyme-phytocompounds 
interactions (Figure 1). Moreover, investigation of amino 
acids involved in interactions showed that the interactions 
between penicillin and glucosyltransferase occurred in 
the predicted cavity number 5, whilst often interactions of 
ar-curcumene and α-pinene occurred in cavity numbers 
2 and 9, respectively, while amino acids involved in the 
interactions between d-limonene and glucosyltransferase 
were not in any of the predicted cavities. 
Antibacterial activity 
The results of the antibacterial activity of P. acaulis 
Table 3. The results of calculated drug -likeness and toxicity of dominant constitutes of Prangos acaulis
Number logP logD TPSA logS GI absorption CYP1A2 
inhibitor 
CYP2C19 
inhibitor
CYP2C9 
inhibitor
CYP3A4 
inhibitor 
Genotoxicity
1 3.578 4.088 0 -2.99 Low No No No No No
2 3.562 4.090 0 -3.63 Low No No No No No
3 4.286 4.362 0 -3.51 Low No No Yes No No
4 4.285 4.131 0 -3.34 Low No No Yes No Yes
5 4.286 4.152 0 -3.31 Low No No Yes No No
6 3.562 4.466 0 -3.05 Low No No No No No
7 3.267 4.710 0 -3.30 Low No No No No No
8 3.267 4.274 0 -3.50 Low No No No No No
9 4.836 6.091 0 -4.52 Low No No No No No
10 4.534 6.110 0 -3.97 Low No No Yes No No
11 3.259 3.552 0 -2.86 Low No No No No No
12 4.534 6.010 0 -4.03 Low No No Yes No No
13 2.357 2.952 20.230 -2.87 high No no no no no
14 4.631 5.761 0 -3.87 low No no yes no no
15 2.642 3.190 20.230 -2.78 high No no no no no
Table 4. The Results of molecular docking studies on dominant 
compounds of Prangos acaulis extract and Streptococcus mutans 
glucosyltransferase
Compound Ki (µM) Gb (kcal/mol)
Alpha-Thujene 276.23 -3.92
P-Cymene 244.11 -3.90
Alpha-Pinene 84.32 -5.11
Camphene 129.21 -4.21
Beta-Pinene 124.34 -4.45
Myrcene 320.21 -4.12
Alpha-Terpinene 188.34 -3.95
D-Limonene 3.79 -4.70
Ar-Curcumene 4.33 -5.03
Alpha-Humulene 92.23 -4.05
3-ethylidene-2-methyl-1-hexen-4-yne 146.43 -2.98
Germacrene D 170.03 -3.45
Terpineol 133.09 -4.02
Caryophyllene 143.07 -4.06
Nerol 156.88 -3.55
Penicilin 3.65 -4.65
extracts against S. mutans are shown in Table 5. All 
tested extracts had antibacterial effects against the tested 
strain in a dose-dependent manner. Consequently, 
most antibacterial effects were observed at the highest 
concentrations. Results also revealed that root extract had 
the most antibacterial activity followed by flower, leaf, 
stem and seed extracts. The MIC and MBC values of the 
tested extract are presented in Table 5. Similarly, to results 
of disc diffusion assay root and seed extract showed most 
and least antibacterial activity with MIC values of 500-
1000, and 2000-3000 respectively, as well as maximum 
and minimum MBC values, were determined for root and 
seed extract  respectively.
Biofilm inhibition activity
The results of potential inhibition of S. mutans biofilm 
formation by P. acaulis extracts are shown in Table 6. The 
results indicated that all the tested extracts particularly 
in 2000 to 3000 µg/mL concentrations could inhibit the 
biofilm formation. Inhibition of the biofilm formation, 
like the antibacterial effects, was in dose-dependent 
manner, so that inhibitory function increased with 
increasing concentration. Results also showed that root 
and seed extracts had the most and the least efficacies in 
inhibition of biofilm formation with 66.40% and 22±0.20% 
reduction, respectively.
Mutagenicity assay
The results of Ames test for determination of the mutagenic 
potential of P. acaulis extracts are presented in Table 7. 
The results confirmed that none of the tested extracts 
had mutagenic effect in the studied concentrations. 
Comparative study of tested extracts indicated that  the 
number of His+ revertant colonies caused by the extracts 
increases with increasing concentrations such that  the 
highest number of the revertant colonies were observed 
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in the highest concentration. Results also showed that 
root and seed extracts with QM values of 1.67±0.31 and 
1.33±0.20 in highest tested concentration had the most 
and the least effects on the number of the revertant 
colonies, respectively
Discussion
Dental caries is one of the costly diseases, most common 
preventable and a global oral health problem in the world. 
Based on the World Health Organization (WHO) report, 
poor oral health may have a dreadful effect on quality of 
life and general health. This chron ic disease is caused by 
the interaction of oral microorganisms, diet and some host 
factors, which among them oral bacteria have a major role 
in the formation and development of dental caries. Acidic 
by-products from the bac terial fermentation of dietary 
carbohydrates are the main cause of the destruction  of 
dental hard tissues that is referred to dental caries (1-3). 
About 700 different bacteria species have been identified 
in the oral cavity. Due to some special abilities of S. mutans 
such as acid production, build up glycogen reserves; 
synthesize extracellular polysaccharides and adherence to 
enamel surfaces. It is believed that the bacteria are the key 
etiological agents in formation and development dental 
caries (4). 
Because of important role of S. mutans in dental caries 
formation, recently, many studies have been conducted 
to introduce novel anti-microbial agents,  especially 
Figure 1. Lowest-energy docking poses of Ar-Curcumene (a), D-Limonene (b), Alpha-Pinene (c) and penicillin (d) with S. mutans 
glucosyltransferase.
Table 5. Antibacterial activity of Prangos acaulis against single form of Streptococcus mutans 
Sample
Concentration (µg/mL)
Inhibition zone (mm)
MIC (μg/mL) MBC (μg/mL) 250 500 1000) 1500 2000 3000
Flower 1000-1500 3000 - 6±0.90 7±0.45 9±1 11±0.25 12±0.10
Leaf 1000-1500 3000 - 5±0.20 6±0.25 7±0.65 9±0.80 11±0.70
Stem 1500-200 >3000 - 5±0.70 6±0.60 7±0.80 9±0.70 10±0.20
Root 500-1000 2000 6±0.8 8±0.30 9±0.10 10±0.25 12±0.50 14±1
Seed 2000-3000 >3000 - - - 5±0.40 7±0.45 8±0.90
Penicillin 200-400 1600 19±0.70
Table 6. The percentage of inhibition of biofilm structure of Streptococcus mutans
Sample
Concentration (µg/mL)
Inhibition (%)
250 500 1000 1500 2000 3000
Flower - 10±1 14±3 20±2 31±3 48±1
Leaf - 10±2.1 12±1 16±1 21±0.30 39±2
Stem - 8±1 10±0.90 13±3 18±1 28±3
Root - 19±0.75 27±1 47±2 59±2 66±0.40
Seed - - - - 15±1 22±0.20
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natural materials against various strains (16,33-35). Due 
to presence of wide range of phytochemicals, lack of 
side effects and proper effect of medicinal plants in the 
recent years many attempts have been done to discover 
and introduce novel antibacterial compounds with 
emphasizing against S. mutans (36-39). The results of 
this study revealed that methanol extract from different 
parts of P. acaulis especially root extract had significant 
antibacterial activity against single form of S. mutans. 
Results also showed that all tested extracts could inhibit 
the biofilm formation in a dose-dependent manner. Our 
previous studies showed that methanol extracts of Prangos 
ferulacea and Satureja khuzestanica Jamzad had potent 
antibacterial activity and inhibited biofilm formation 
of S. mutans (21). Hwang et al confirmed that methanol 
extract from some medicinal plants including Baeckea 
frutescens, Glycyrrhiza glabra, Kaempferia pandurata, 
Physalis angulata and Quercus infectoria had potent 
antibacterial activities against cariogenic bacterium 
S. mutans (40). Similarly, Jebashree et al revealed that 
hexane, ethyl acetate, ethanol and methanol extracts of 
Psidium guajava, Terminalia chebula, Mimusops elengi and 
Achyranthes aspera had significant antibacterial activities 
against S. mutans (41). In another study, it was found that 
aqueous extracts of Sappan lignum, Coptidis rhizoma, 
and Psoraleae semen effectively inhibited the growth of 
oral bacteria (42). Also, some studies have been done 
to evaluate the anti-biofilm activity of medicinal plants. 
Barnabe and colleagues confirmed antibiofilm activity 
of obtained extract from Dioscorea altissima and Annona 
hypoglauca against a single-bacteria biofilm of S. mutans 
(43). The methanol extracts of Camellia japonica and 
Thuja orientalis were investigated for determining ability 
to inhibit S. mutans biofilm formation. The results showed 
that the mentioned plants could inhibit the biofilm with 
an effectiveness of over 90% (44). In a similar research lee 
et al revealed that S. mutans biofilm had the highest level 
of sensitivity for the extract of Sophora flavescens (45).
Furthermore,  several studies aimed at investigating 
the anti-bacterial and anti-biofilm activities of pure 
phytochemicals and some compounds such as linoleic, 
linolenic, oleanolic, betulinic acids, betulin, beta-sitosterol 
glucoside and carvacrol introduced as effective compounds 
against dental caries development and S. mutans biofilm 
formation (16,46,47). Due to costly and time consuming 
of convention methods for evaluation, drug likeness 
and anti-bacterial activities of phytochemicals currently 
in silico methods have been regarded. Therefore, some 
studies were planned to in silico screen the effective 
compounds with anti-biofilm and antibacterial activities 
(48,49). The results of the present study confirmed that 
ar-curcumene, d-limonene, and alpha-pinene had strong 
and appropriate interactions to glucosyltransferase and 
could be good candidates for inhibiting S. mutans biofilm 
formation and dental caries development. In this regard, 
our previous studies showed that some phytochemicals 
such as carvacrol, α-pinen, limonene, gama-terpinen, beta-
bisabolene, gosferol, psoralen and p-cymen were good 
candidates for investigating the antibacterial activities 
(20). Similarly, in a structure-based virtual screening 
study it was revealed that betulin and 3,12-oleandione 
could inhibit S. mutans glycosyltransferase, efficiently 
(50).  In another structure-based virtual screening study, 
it was found that quinoxaline derivative could be a good 
candidate as a potential glucosyltransferase inhibitor (8).
In conclusion, based on the results of the present study 
P. acaulis can be a good candidate for more study and 
development of a natural anti-dental caries agent. 
Conclusion
This study was planned to in silico and in vitro evaluate 
the anti-bacterial and anti-biofilm activities of methanol 
extracts of P. acaulis and investigate their potential 
mutagenicities. The results showed that the extracts 
especially root extract had significant antibacterial 
activities against a single form of S. mutans. Results also 
showed that all the extracts could inhibit the biofilm 
formation in a dose-dependent manner without any 
mutagenic effects. In silico analysis revealed that ar-
curcumene, d-Limonene and alpha-Pinene could be good 
candidates for inhibition of S. mutans biofilm formation 
and development. Therefore, the plant and its by-products 
might be good candidates for introduction as new drugs.
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